FORT COLLINS, Colo.–(BUSINESS WIRE)–VetDC, Inc., a veterinary cancer therapeutics company, today announced that the Company has received three major technical section complete letters for TanoveaTM (rabacfosadine) from the U.S. Food and Drug Administration’s Center for Veterinary Medicine (FDA-CVM). Upon approval, Tanovea will be the first on-label therapeutic option for use in dogs with lymphoma, one […]
June 07, 2016 01:55 PM Eastern Daylight Time FORT COLLINS, Colo.–(BUSINESS WIRE)–VetDC, Inc., a veterinary cancer therapeutics company, today announced the successful conclusion of a new field study of TanoveaTM (rabacfosadine), a novel small molecule therapy being developed as a treatment for lymphoma in dogs. This study evaluated the use of alternating Tanovea in combination […]
BROOMFIELD, CO–(Marketwired – March 24, 2016) – ViroCyt®, the leader in rapid virus quantification, announced today that it has developed and launched an antibody-based detection system for influenza capable of determining virus titer for both flu A and flu B during a one minute analysis. Every year, the flu virus causes millions of cases of […]
BOULDER, CO–(Marketwired – January 19, 2016) – ViroCyt®, the leader in rapid virus quantification, announced today the release of the most recent addition to its ViroTag® portfolio: ViroTag AAV2-3. When combined with the Virus Counter® 3100, this reagent enables real-time quantification of Adeno-associated virus serotypes 2 and 3, both of which are currently being developed […]
BOULDER, CO–(Marketwire – September 29, 2015) – ViroCyt, the leader in rapid virus quantification, announced today the introduction of a new paradigm in virus quantification building upon its award winning Virus Counter technology. The importance of viruses as both a health threat and as a tool for addressing a growing list of diseases continues to increase […]
WESTMINSTER, Colo.–(BUSINESS WIRE)–Surefire Medical, Inc., developer of a new class of direct-to-tumor treatment delivery devices employed in minimally invasive chemoembolization and radioembolization procedures, announced that the company has received 510(k) FDA clearance for the Surefire Precision. The advanced infusion technology’s unique expandable tip increases drug delivery into the tumor while protecting healthy tissue. “This is […]
BOULDER, CO–(Marketwired – June 17, 2015) – ViroCyt, the leader in rapid virus quantification, announced today that it has secured over $4 million in private investment. The financing was led by a strategic investor with significant participation by existing shareholders. ViroCyt will use the capital to expand its global reach by adding new distributors in […]
BOULDER, CO–(Marketwired – Nov 12, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today that it has received the “Rising Star” award from the Colorado Bioscience Association after being nominated as one of three companies in the category. “The Colorado BioScience Association’s Rising Star award recognizes early stage growth companies that have […]
BOULDER, CO–(Marketwired – Aug 13, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today that its breakthrough Virus Counter instrument is being used by a group of laboratories to develop filovirus medical countermeasures. The Filovirus Animal Nonclinical Group or “FANG” is a US interdepartmental and interagency group established to support and facilitate the creation […]
By Jane Byrne, August 1, 2014 A new, sustainable protein source for animal and fish feed is on the horizon, with its US developer getting ready to hit the start button on the production line at its facility in Ohio. http://www.feednavigator.com/Suppliers/Bacteria-beats-insects-and-algae-hands-down-Nutrinsic-CEO-talks-up-new-feed-protein-source-from-factory-wastewater
By Alicia Wallace, Camera Business Writer Boulder-based LogRhythm has raised $40 million, a funding round that company officials say could vault the security intelligence and compliance firm to position for an eventual initial public offering. The equity investment, which is LogRhythm’s largest round to date, was led by Riverwood Capital and included participation from Piper […]
GLENDALE, CO–(Marketwired – July 18, 2014) – Nutrinsic Corporation (www.nutrinsic.com) has announced the launch of its sustainable protein business. ProFloc™, a high quality protein ingredient for use in animal nutrition, is produced using patented technology that upcycles nutrients that are currently lost in food and beverage plant wastewater treatment. ProFloc™ is therefore a sustainable and earth-friendly […]
BOULDER, CO–(Marketwired – Jun 11, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today that Michael Olszowy, PhD, has joined the team as Chief Technology Officer. Dr. Olszowy is a formally trained cellular and molecular immunologist with 16 years of experience developing and commercializing life science technologies. Most recently, he held a […]
BOULDER, CO–(Marketwired – Mar 25, 2014) – ViroCyt, LLC, the leader in rapid virus quantification, announced today the introduction of the next generation Virus Counter at the World Vaccine Congress being held in Washington, DC. The Virus Counter technology has already been adopted by the leading companies in the fields of viral vaccine development and […]
Written by: Sarah Perez Cobook, the scrappy startup out of Latvia which grew its universal address book application to over a million users, is being acquired by FullContact, a larger Denver-based operation also working on contact management solutions for businesses and individuals. Going forward, the entire six-person Cobook team will relocate to Denver, where Cobook CEO […]
Posted by Stephen Levy The Colorado medical device industry is as diverse as the state’s terrain. Centered, not surprisingly, along the metro corridor of Fort Collins, Denver, Boulder, and Colorado Springs, these companies range from a Sandoz unit of giant Novartis in Broomfield to Denver’s Eldon James, whose BioMed cleanroom facility focuses on the manufacture of products designed for the life sciences, biomedical, pharmaceutical […]
Study evaluates eliminating coiling by using the novel anti-reflux Surefire Infusion System in radioembolization procedures WESTMINSTER, Colo., Dec. 11, 2013 /PRNewswire/ — Surefire Medical, Inc. today announced that it has completed enrollment in the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial. This randomized prospective study investigates the feasibility and benefits of performing […]
AktiVax is a medical device company developing novel reconstitution and delivery technologies for the vaccine and biologic pharmaceutical industries.
QualVu is changing the qualitative research industry through an innovative video-based platform that enables clients to connect with their customers, gather rich insights, and make better business decisions.
Sinopsys is a medical device company developing new technology for the lacrimal system.